Argenx SE (formerly arGEN-X) is the Dutch branch of the Belgian company Argenx BV, which is engaged in developing biotechnological products. argenx SE is listed on NASDAQ in the United States and Euronext Brussels.
The company has subsidiaries in the Netherlands, Belgium, Japan, Switzerland, the Netherlands, Canada, and the United States. Argenx won a spot in the BEL 20 in June 2018.
Argenx’s beurswaards traded for little under 14 million euros on Euronext Brussels in February 2021. Therefore, Het Biotech Company was more valuable than Umicore, Solvay, or Ageas. He was the best-performing component of the Bel20-index in 2020, with a 68,5% increase.
Het middel efgartigimod with the trade name “VYVGART” was approved by the American FDA in December 2021. Argenx announced in 2021 that 130 individuals with the CIDP (Chronische inflammatoire demyeliniserende polyneuropathie) condition would be subjected to effgartigimod testing.
With 44 million outstanding shares and a market capitalization of $29,98 billion, ARGX stock is currently trading at $535.71. On NASDAQ, the ARGX is traded under the symbol ARGX. In the previous day, the price of ARGX increased by 1.37%. The present outlook for the price of ARGX stock is optimistic.
Since 2017, splits and dividends have been taken into account in the Argenex SE historical daily share price chart and data. Argenex SE’s most recent closing share price as of July 20, 2023 is 534.95.
On July 20, 2023, the closing price of Argenex SE stock reached an all-time high of 534.95.
The 52-week high stock price for Argenex SE is 536.48, which is 0.3% higher than the price of the stock now.
The 52-week low stock price for Argenex SE is 333.07, or 37.7% less than the current share price.
The 52-week average price of Argenex SE stock is 381.01.
By July 26, 2023, the value of argenx SE shares will increase by 8.11% and reach $ 579.17 per share, based on our most recent ARGX stock forecast. Our technical indicators indicate that the market is now bullish, despite the Fear & Greed Index reading of 39 (Fear). In the previous 30 days, the ARGX stock experienced 3.61% price volatility and 14/30 (47%) green days. Argenx SE stock is currently selling 7.50% below our projection, making this a good time to buy ARGX stock.
If argenx SE shares continue to increase at the same average annual rate as they did over the previous ten years, the argenx SE stock forecast for 2025 is currently $1,399.50. The price of ARGX shares would grow by 161.24% as a result.
If the argenx SE stock continues to increase at its current 10-year average rate, it will reach a value of $15,437 in 2030. If the argenx SE stock forecast for 2030 comes true, the price of the ARGX stock will increase by 2,781.69% from the present.
In an exciting step forward for BOMT, LDA Capital has committed $10 million to help…
Artificial Intelligence (AI) is transforming industries, driving innovations in healthcare, finance, autonomous vehicles, robotics, entertainment……
The best crypto presales market has a new rising star – Artemis Coin (ARTMS). This project stands…
In an inspiring display of compassion and innovation, the cryptocurrency community has come together to…
As global awareness of carbon emissions grows, the push for sustainable solutions has become more…
We are excited to announce that Rexas Finance successfully joined WOW Summit 2024 as a Gold Partner,…
This website uses cookies.